Human omentum fat-derived mesenchymal stem cells transdifferentiates into pancreatic islet-like cluster

Cell Biochemistry and Function

Volumn 31, Issue 7, 2013, Pages 612-619

  Dhanasekaran, M ^a   Indumathi, S ^b   Harikrishnan, R ^a   Mishra, Rashmi ^a   Lissa, Rp ^a   Rajkumar, J S ^a   Sudarsanam, D ^b  

^a Lifeline Multispeciality Hospital   (India)

^b LOYOLA COLLEGE   (India)

Author keywords

Diabetes mellitus; Islet like cluster; Mesenchymal stem cells; Omentum fat; Transdifferentiation

Indexed keywords

DITHIZONE; HOMEODOMAIN PROTEIN; INSULIN; NESTIN; TRANSCRIPTION FACTOR PDX 1;

ARTICLE; CELL TRANSDIFFERENTIATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INSULIN RELEASE; MESENCHYMAL STEM CELL; OMENTUM; PANCREAS ISLET; PANCREAS ISLET CELL; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

DIABETES MELLITUS; ISLET-LIKE CLUSTER; MESENCHYMAL STEM CELLS; OMENTUM FAT; TRANSDIFFERENTIATION;

ABDOMINAL FAT; ADULT; ANTIGENS, SURFACE; CELL TRANSDIFFERENTIATION; HUMANS; ISLETS OF LANGERHANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OMENTUM;

EID: 84884980521     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2948     Document Type: Article

References (37)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006; 29: 2114-2116.
3. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
4. Yechoor V, Chan L. Mini review: β-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation. Mol Endocrinol 2010; 24: 1501-1511.
5. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
6. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010; 1: 19.
7. Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol 2002; 197: 519-526.
8. Halban PA. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat Cell Biol 2004; 6: 1021-1025.
9. Chelluri LK, Kancherla R, Turlapati N, et al. Improved differentiation protocol of rat bone marrow precursors to functional islet like cells. Stem Cell Studies 2011; 1: 36-41.
10. Sordi V, Melzi R, Mercalli A, et al. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 2010; 28: 386-386.
11. Sun Y, Chen L, Hou XG, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J 2007; 120: 771-776.
12. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 2004; 84: 607-617.
13. Timper K, Seboek D, Eberhardt M, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006; 341: 1135-1140.
14. Locke M, Windsor J, Dunbar PR. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 2009; 79: 235-244.
15. Yanxia Zhu TL, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 2008; 26: 664-675.
16. Garcia-Olmo D, Garcia-Arranz M, Herreros D. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opin Biol Ther 2008; 8: 1417-1423.
17. Bai X, Yan Y, Song YH, et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010; 31: 489-501.
18. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
19. Aust L, Devlin B, Foster SJ, Halvorsen YD. Yield of human adipose derived adult stem cells from liposuction aspirates. Cytotherapy 2004; 6: 7-14.
20. Varma MJ, Breuls RG, Schouten TE, et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev 2007; 16: 91-104.
21. Tholpady SS, Katz AJ, Ogle RC. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec 2003; 272A: 398-402.
22. Singh AK, Patel J, Litbarg NO, et al. Stromal cells cultured from omentum express pluripotent markers, produce high amount of VEGF, and engraft to injured sites. Cell Tissue Res 2008; 332(8): 81-88.
23. Baglioni S, Francalanci M, Squecco R, et al. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 2009; 23: 3494-3505.
24. Toyoda M, Matsubara Y, Lin K, Sugimachi K, Furue M. Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omentum adipose tissues. Cell Biochem Funct 2009; 27: 440-447.
25. Dhanasekaran M, Indumathi S, Kanmani A, et al. Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow. Cytotechnology 2012; 64(5): 497-509.
26. Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 1979; 28: 1198-1205.
27. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism 1991; 40: 990-996.
28. Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omentum and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983; 32: 117-123.
29. Kannel WB, Cupples LA, Ramaswami R, Stokes J, 3rd, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991; 44: 183-190.
30. Von Eyben FE, Mouritsen E, Holm J, et al. Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 2003; 27: 941-949.
31. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. Circulation 2007; 116: 1234-1241.
32. Seeberger KL, Dufour JM, Shapiro AM, Lakey JR, Rajotte RV, Korbutt GS. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 2006; 86: 141-153.
33. Chandra V, G S, Muthyala S, et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One n. d; 6(6): e20615. doi:10.1371/journal.pone.0020615.
34. Okura H, Komoda H, Fumimoto Y, et al. Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs 2009; 12: 123-130.
35. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005; 23: 412-423.
36. Dhanasekaran M, Indumathi S, Lissa RP, Harikrishnan R, Rajkumar JS, Sudarsanam D. A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition. Cytotechnology 2012. doi:10.1007/s10616-012-9471-0.
37. Potdar PD, Jyoti PS. Establishment and molecular characterization of mesenchymal stem cell lines derived from human visceral & subcutaneous adipose tissues. J Stem Cells Regen Med 2010; 6: 26-35.